semaglutide prediabetes progression to diabetes remission reduce the global burden of type 2 Oral semaglutide improves blood sugar,

None of our products are medication or drugs

Understanding the underlying mechanisms, your individual biomarker profile, and evidence-based management strategies can help you have a more informed conversation with your healthcare provider about optimizing your treatment e

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

For many people, GLP-1 medications are part of long-term weight management, not something you take for a few months and stop